Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Inflammation01:38

Inflammation

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Variant profile of Brazilian patients with Sanfilippo syndrome type B.

Genetics and molecular biology·2026
Same author

Performance of the MAGGIC Score in Individuals with Heart Failure: Validation in a Brazilian Population.

Arquivos brasileiros de cardiologia·2026
Same author

Genetic insights into the peoples who shaped the American continent.

Genetics and molecular biology·2026
Same author

Liposomal CRISPR/Cas9-Mediated Local Genome Editing for Joint Disease in Mucopolysaccharidosis Type I.

Pharmaceutics·2026
Same author

Conduction System Pacing vs Biventricular Pacing in Chronic Heart Failure: Protocol for the Economic Analysis of the PhysioSync-HF Trial.

Arquivos brasileiros de cardiologia·2026
Same author

Effect of Intravenous Iron Combined With Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) on Ventricular Function and Myocardial Iron Content in Patients With Heart Failure With Reduced Ejection Fraction-Rationale for the COMBINED-HF Study.

Journal of cardiac failure·2026

Related Experiment Video

Updated: Jun 7, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

Bone marrow derived cells decrease inflammation but not oxidative stress in an experimental model of acute myocardial

Angela Maria Vicente Tavares1, Alex Sander da Rosa Araújo, Guilherme Baldo

  • 1Cardiovascular Research Laboratory, Hospital de Clinicas de Porto Alegre, Porto Alegre-RS, Brazil.

Life Sciences
|October 26, 2010
PubMed
Summary
This summary is machine-generated.

Bone marrow cell therapy did not improve cardiac function post-heart attack in rats. However, it reduced inflammation and altered redox status, suggesting an anti-inflammatory effect.

More Related Videos

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

Related Experiment Videos

Last Updated: Jun 7, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

Area of Science:

  • Cardiovascular Research
  • Regenerative Medicine
  • Oxidative Stress Biology

Background:

  • Bone marrow cell (BMC) therapy is investigated for its potential to improve heart function after myocardial infarction (MI).
  • Early post-MI cardiac function, inflammation, and redox balance are critical determinants of recovery and long-term outcomes.
  • Understanding the interplay between BMCs, inflammation, and oxidative stress is crucial for developing effective therapeutic strategies.

Purpose of the Study:

  • To assess the impact of BMC therapy on cardiac function in a rat model of myocardial infarction (MI).
  • To investigate the correlation between BMC treatment, cardiac inflammation, and redox status in the early post-MI period.

Main Methods:

  • Male Wistar rats underwent sham operation or MI induction via coronary artery ligation.
  • Rats were randomized into four groups: Sham (S), MI, Sham+Treatment (ST), and MI+Treatment (AMIT).
  • BMC therapy was administered immediately post-MI. Cardiac function was assessed via echocardiography. Myocardial levels of TNF-α and IL-6, and oxidative stress markers (GSH/GSSG ratio, H2O2, lipid/protein oxidation, antioxidant enzyme activities) were measured 48 hours post-MI.

Main Results:

  • Ejection fraction did not significantly improve in BMC-treated MI rats compared to untreated MI rats.
  • Myocardial expression of pro-inflammatory cytokines TNF-α and IL-6 was reduced by BMC therapy.
  • The reduced glutathione (GSH) to oxidized glutathione (GSSG) ratio, an indicator of oxidative stress, decreased significantly in BMC-treated MI rats.

Conclusions:

  • BMC therapy in the early phase post-MI did not enhance cardiac function in this rat model.
  • BMC administration exerted an anti-inflammatory-like effect by reducing myocardial pro-inflammatory cytokine levels.
  • BMCs appeared to promote a myocardial redox status favoring the oxidation of pro-inflammatory mediators.